News
Datroway joins Trodelvy for frontline TNBC in the EU
AstraZeneca and Daiichi Sankyo's Datroway enters the first-line triple-negative breast cancer market in the EU, taking on Gilead's Trodelvy.
News
Adcomm backs Replimune melanoma drug, despite data concern
Replimune's RP1 immunotherapy for melanoma clears advisory committee vote by 10 to three, despite FDA concerns about the design of the IGNYTE study.
News
UK patient first in world to get novel lung cancer vaccine
A woman from the Wirral in the UK has become the first patient in the world to receive an experimental, personalised lung cancer vaccine.
News
Ultomiris fail mars AZ's strong Q2 results
AstraZeneca has served up a robust set of interim results, leavened by strong sales of cancer drugs, but with some mixed pipeline news on the side.
News
J&J's multiple myeloma duo aces phase 3 trial
Two of Johnson & Johnson's multiple myeloma bispecifics, Tecvayli and Talvey, have dramatically improved survival when used as a second-line regimen.
News
Views & Analysis
Deep Dive
Editor's Picks
Editor's Picks
